RMTC: Volume 50-6, June 2024: Anti-Cancer Vaccines

RMTC: Volume 50-6, June 2024: Anti-Cancer Vaccines

2024-06-28 19:46:13

Table of contents

Preview

Reducing the potential effectiveness, actual effectiveness, and immunogenicity of HPV vaccination programs: a review of existing evidence
J Montroy, MI Salvadori, N Forbes, V Dubey, S Almasri, A Jirovec, C Yan, K Gusic, A Stevens, K Young, M Tunis

monitor

Healthcare-associated infections and antimicrobial resistance in acute care hospitals in Canada, 2018-2022
Canadian Hospital Infection Surveillance Program

Infections associated with medical devices and surgical procedures in acute care hospitals in Canada, 2018-2022
Canadian Hospital Infection Surveillance Program

scoping review

Topic description of factors associated with extended-spectrum β-lactamase-producing Enterobacteriaceae in humans
J. Goltz, C. Ulan, S. Pierce, C. Murphy, C. Carson, J. Parmley

epidemiological research

Characteristics associated with SARS-CoV-2 screening, infection, and vaccination rates among non-healthcare essential workers in Montreal, 2021
C Kaya, D Menzies, J Papenburg, C Jansuni, J Campbell

1724562137
#RMTC #Volume #June #AntiCancer #Vaccines

Leave a Replay